A popular skin care drug—which is intended to target eczema—was just found to have an unusual side effect: hair growth. According to an article on Newsweek, the FDA-approved drug dupilumab was given to a 13-year-old alopecia sufferer to treat her eczema. The patient, who hadn’t grown hair on her scalp since she was two, suddenly grew a significant amount of hair on her head after continual use of the drug, a study in the journal JAMA Dermatology reports.
Dr. Carlos Wesley, a hair restoration surgeon in Manhattan, said that women in his practice respond better to P.R.P. than men do, which may have something to do with the fact that women with genetic hair loss tend to have more inflammatory cells around the follicles. From 2013 to 2014, he said, he had an 83 percent increase in female patients, in part because of P.R.P.
He now enjoys full scalp coverage, which he credits to modern transplant techniques combined with Propecia – but when he embarked on what he refers to as his “hair-loss journey”, there weren’t so many options. One trichologist advised him to dunk his head in freezing cold water six times per day; another zapped his scalp with infra-red light; finally, he opted for surgery. “The techniques were far less refined – 450 grafts,” he says. “Now, we can move 4,500 grafts in a single session. It left me with scars at the back of my head. And I committed to more and more procedures. Each time, they were taking another strip of tissue from the back of my head, leaving another scar.” He was eventually “fixed” at a surgery in Vancouver, but in his present role he talks people out of surgery as much as talking them into it. “I wish I could turn back the clock so I never had surgery,” he says.
In either sex, hair loss from androgenetic alopecia occurs because of a genetically determined shortening of anagen, a hair's growing phase, and a lengthening of the time between the shedding of a hair and the start of a new anagen phase. (See "Life cycle of a hair.") That means it takes longer for hair to start growing back after it is shed in the course of the normal growth cycle. The hair follicle itself also changes, shrinking and producing a shorter, thinner hair shaft — a process called "follicular miniaturization." As a result, thicker, pigmented, longer-lived "terminal" hairs are replaced by shorter, thinner, non-pigmented hairs called "vellus."
Due to the concern of several readers, I’ve removed the link to the new Trinov website that has popped up on the net. For now, the website only contains an email address subscription box which really poses no issue to anyone who subscribed. At this time, it’s not confirmed who the actual owner of the new Trinov site is, so use your discretion until we find out more regarding this matter. Until more information is known the website will not be shared on Follicle Thought.
1. Minoxidil. It’s the only FDA-approved topical nonprescription medication that can claim to regrow hair — and it should be part of any hair-loss plan if you have serious thinning, says Rogers. Minoxidil has loads of research to back it, but it requires commitment. If you quit using it, your hair will start to lose ground again. Use a 5 percent strength, like Women’s Rogaine 5% Minoxidil Foam ($30), once daily to see results in three to four months, says Rogers.
Hair loss is more common than you think and it can happen to anyone. According to Michele J Farber, MD of Schweiger Dermatology Group in NYC, causes range from, “androgenetic or hormone-related hair loss, stress related-hair loss, also called telogen effluvium, and dandruff. Medications, vitamin deficiencies, thyroid disorders, excess styling, and autoimmune disorders can also cause hair loss and thinning.” But the good news is, there are viable solutions, starting with topical growth treatments.
Dupilumab is FDA approved for treating eczema aka atopic dermatitis and sold under the brand name Dupixent. As the story goes, a patient with alopecia totalis (a form of areata which leaves a person’s head completely bald) was being treated for eczema by the drug Dupixent. After 6 weeks the patient first began to notice progress in terms of hair growth and at 7 months she had noticeable pigmented hair growth on her scalp. Notably, the patient stopped taking the dupilumab for a period of time and noticed her growth subsided; when she began taking the drug again the hair improved once more. This provides another useful therapy option for patients seeking treatment for AA. One would imagine a topical version would be worthwhile to investigate.